[Adjuvant therapy after treatment of hepatocellular carcinoma]

Nihon Shokakibyo Gakkai Zasshi. 2008 Jun;105(6):787-94.

[Article in Japanese]

Authors

Kazuhiro Kasai¹, Hidekatsu Kuroda, Kazuyuki Suzuki

Affiliation

¹ Department of Gastroenterology and Hepatology, Iwate Medical University.

PMID: 18525183

No abstract available

Publication types

Review

MeSH terms

Amino Acids, Branched-Chain / therapeutic use
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Antineoplastic Agents / therapeutic use
Carcinoma, Hepatocellular / prevention & control
Carcinoma, Hepatocellular / therapy*
Diabetes Mellitus
Humans
Immunotherapy, Adoptive
Interferons / therapeutic use
Lamivudine / therapeutic use
Liver Neoplasms / prevention & control
Liver Neoplasms / therapy*
Neoadjuvant Therapy*
Neoplasm Recurrence, Local / prevention & control
Obesity
Randomized Controlled Trials as Topic
Risk Factors
Tretinoin / analogs & derivatives
Tretinoin / therapeutic use
Vitamin K / therapeutic use

Substances

Amino Acids, Branched-Chain
Angiotensin-Converting Enzyme Inhibitors
Antineoplastic Agents
Vitamin K
Lamivudine
Tretinoin
3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid
Interferons